Spectral AI, Inc. - Class A Common Stock (MDAI)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Mar 31, 2026Investment Snapshot
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 10.3% — below-average profitability
- Revenue declining 34% annually
Spectral AI, Inc. - Class A Common Stock (MDAI) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $46 million . Key value metrics: Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Spectral AI, Inc. - Class A Common Stock — Fundamental Analysis Summary
On financial health, MDAI shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 10.3% (sector average: -19.8%).
StockPik's composite Value Score for MDAI is 50/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MDAI reports a solid gross margin of 45.3% (sector average: 33.5%) and a negative operating margin of -30.5%.
MDAI shows revenue declining at 34% year-over-year, with earnings growing at 51%.